Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McColgan

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|February 11, 2012
Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic reviewNazeeha Hasan, Peter McColgan, Paul Bentley, et al.
Movement Disorders Clinical Practice|February 20, 2025
Neuroimaging Techniques in Huntington's Disease: A Critical ReviewMena Farag, Harry Knights, Rachael I Scahill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's diseaseAngeliki Zarkali, Peter McColgan, Louise Ann Leyland, et al.
Biometrics|December 19, 2019
Identifying disease-associated biomarker network features through conditional graphical modelShanghong Xie, Xiang Li, Peter McColgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 9, 2021
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's DiseaseAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Frontiers in Neuroscience|July 18, 2024
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysisMatthias Machacek, Elena Garcia-Montoya, Peter McColgan, et al.
Communications Biology|January 20, 2021
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's diseaseAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Neurology|February 26, 2020
Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunctionAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Neurology|May 2, 2025
Modeling Disease Progression and Placebo Response in Huntington Disease: Insights From Enroll-HD and GENERATION HD1 CohortsMarcelo Boareto, Yumi Yamamoto, Jeffrey D Long, et al.
Frontiers in Genetics|October 19, 2018
Learning Subject-Specific Directed Acyclic Graphs With Mixed Effects Structural Equation Models From Observational DataXiang Li, Shanghong Xie, Peter McColgan, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|February 11, 2012
Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic reviewNazeeha Hasan, Peter McColgan, Paul Bentley, et al.
Movement Disorders Clinical Practice|February 20, 2025
Neuroimaging Techniques in Huntington's Disease: A Critical ReviewMena Farag, Harry Knights, Rachael I Scahill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's diseaseAngeliki Zarkali, Peter McColgan, Louise Ann Leyland, et al.
Biometrics|December 19, 2019
Identifying disease-associated biomarker network features through conditional graphical modelShanghong Xie, Xiang Li, Peter McColgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 9, 2021
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's DiseaseAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Frontiers in Neuroscience|July 18, 2024
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysisMatthias Machacek, Elena Garcia-Montoya, Peter McColgan, et al.
Communications Biology|January 20, 2021
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's diseaseAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Neurology|February 26, 2020
Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunctionAngeliki Zarkali, Peter McColgan, Louise-Ann Leyland, et al.
Neurology|May 2, 2025
Modeling Disease Progression and Placebo Response in Huntington Disease: Insights From Enroll-HD and GENERATION HD1 CohortsMarcelo Boareto, Yumi Yamamoto, Jeffrey D Long, et al.
Frontiers in Genetics|October 19, 2018
Learning Subject-Specific Directed Acyclic Graphs With Mixed Effects Structural Equation Models From Observational DataXiang Li, Shanghong Xie, Peter McColgan, et al.
Pageof 6